Afatinib: A first-line treatment for selected patients with metastatic non-small-cell lung cancer. [electronic resource]
Producer: 20150629Description: 1933-8 p. digitalISSN:- 1535-2900
- Afatinib
- Antineoplastic Agents -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Drug Resistance, Neoplasm
- ErbB Receptors -- antagonists & inhibitors
- Humans
- Lung Neoplasms -- drug therapy
- Mutation
- Neoplasm Metastasis
- Protein Kinase Inhibitors -- adverse effects
- Quinazolines -- adverse effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.